Home
CSA Schedules
Categories
All substances
Recently added
Cannabinoids
Cathinones
Ergolines
Phenethylamines
Piperazines
Steroid esters
Tryptamines
PiHKAL
TiHKAL
Bill S. 3187
Proposed
Revoked
Unclassified
Resources
Databases
Legal decisions
References
Vendors
Search for a substance:
«
Mefenorex
»
Identity
Properties
Spectra
Vendors
References
Databases
Variations
CSA Names:
Mefenorex
CSA Location:
Schedule IV Section (f) Subsection (6)
DEA code 1580
CSA History:
53 FR 17459
added (and renumbered subsequent entries) effective 16 Jun 1988
Names:
3-Chloro-
N
-(1-phenylpropan-2-yl)propan-1-amine (IUPAC)
Molecular formula:
C
12
H
18
ClN
Nominal mass:
211
Average mass:
211.7310
Monoisotopic mass:
211.112777
CAS registry number:
17243-57-1
ChemSpider:
20467
PubChem:
21777
Wikipedia:
Mefenorex
Erowid:
Drugs-Forum:
Bluelight:
Standard InChI:
InChI=1S/C12H18ClN/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,8-10H2,1H3
Standard InChI key:
XXVROGAVTTXONC-UHFFFAOYSA-N
SMILES:
ClCCCNC(Cc1ccccc1)C
Tags:
USCSA,phenethylamine
Property
Value
Remarks
Property
Value
Remarks
Location
Type
Remarks
Mefenorex MS (NIST).pdf
EI MS
Used with the permission of NIST Mass Spectrometry Data Center Collection (C) 2008 copyright by the U.S. Secretary of Commerce on behalf of the United States of America. All rights reserved.
mefenorex cnd.pdf
UV FTIR EI MS
Used with permission of CND Analytical. From "Analytical Profiles of the Amphetamines and Related Phenethylamines"
Vendor
ID
URL
Cerilliant
NMID283
http://www.cerilliant.com/shoponline/Item_Details.aspx?itemno=3fe60ce9-7fd1-45ad-8b57-84ff889721cb
Toronto Research Chemicals
M205200
https://www.trc-canada.com/detail.php?CatNum=M205200
Title
Publication
Date
Vol. Iss. Page(s)
Remarks
Title
Publication
Date
Vol. Iss. Page(s)
Remarks
Database
ID
URL
NIST/EPA/NIH Mass Spectral Library 2011
Wiley Registry of Mass Spectral Data, 10th Edition
Mass Spectral Library of Drugs, Poisons, Pesticides, Pollutants
Substance name
Substance name
Please
send us
your comments, questions or suggestions · Collaborate with colleagues at
Forendex Forum
•
Updated 3 March 2017